Retina

The partnership will use ocular imaging to build an AI foundation model and identify new genetic targets for degenerative diseases

The recent agreement with Cipla adds to the list of partnerships Formosa has formed for APP13007.

This database could enhance the workflow of eye care professionals with its in-depth reference data for retinal layer thickness and optic nerve head metrics.

PYK-2101 is a first-in-class biodegradable retinal hydrogel sealant.

This device is designed to assist healthcare professionals in analyzing fundus images for the early detection of key retinal conditions.

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery.

The researchers successfully tested the robot using enucleated pig eyes.

The imaging system is designed to enable secure, real-time remote monitoring around the clock, from virtually any location.

This research project, titled, “A Generalizable Deep Learning Platform for Unifying Quantification of Experimental Autoimmune Uveitis.”

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

The role of compounded anesthetic formulations in streamlining efficiency and elevating patient care.

The 15th annual meeting, taking from March 24–28 in Snowmass, Colorado, will deliver high-impact discussions on macular disease, artificial intelligence in ophthalmology, and breakthrough therapies—plus opportunities for networking on and off the slopes.

A recent study of AEYE-DS AI technology used in conjunction with the Topcon NW500 resulted in exceptional clinical diagnostic efficacy.

A look at the current state of AI in diabetic eye disease and where the future may take us.

The pandemic caused an overall decrease in the rates of the 10 most common ophthalmic procedures performed in 2020 when compared to the year prior.

The Sentinel Camera aims to address critical gaps in retinal disease screening by offering a portable device that captures high-quality images that require no dilation of the eye.

The NeurEYE research team will use millions of eye scans from Scottish optometrists to create the data set.

Cost among other factors may deter patients from screening, especially in rural and low-resource settings.

A Helsinki University Hospital study found diabetes, glycemic control, or insulin therapy did not significantly affect anatomical or functional outcomes after epiretinal membrane surgery.

Within 4 months of AEYE-DS's deployment, diabetic retinopathy screening adherence increased from 29 percent to 49 percent.

The Belgian B Corp company, founded in 2016, is partially owned by Rayner and distributed in over 20 European countries.

The Foundation has assembled a multidisciplinary team of leading scientists, researchers, and physicians from multiple institutions, all focused on accelerating convergent technologies.

In a study, a team of Korean researchers developed an AI model using OCT images to predict neovascular AMD treatment outcomes after anti-VEGF injections. The model highlights AI’s potential in personalized ophthalmic care.

Avant Technologies and Ainnova Tech have partnered to develop a low-cost retinal camera integrated with Ainnova’s Vision AI platform for early detection of ocular and systemic diseases. The technology will be marketed as a SaaS platform for primary care settings.